HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yang Hu Selected Research

CBD3 peptide

5/2019CRMP2-derived peptide ST2-104 (R9-CBD3) protects SH-SY5Y neuroblastoma cells against Aβ25-35-induced neurotoxicity by inhibiting the pCRMP2/NMDAR2B signaling pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yang Hu Research Topics

Disease

67Neoplasms (Cancer)
01/2022 - 06/2006
38Inflammation (Inflammations)
08/2022 - 06/2009
29Infections
02/2022 - 05/2004
18Alzheimer Disease (Alzheimer's Disease)
10/2022 - 11/2010
16Carcinoma (Carcinomatosis)
11/2021 - 11/2008
16Parkinson Disease (Parkinson's Disease)
07/2021 - 11/2013
14Hypoxia (Hypoxemia)
01/2022 - 06/2007
11Wounds and Injuries (Trauma)
08/2022 - 10/2009
11Weight Loss (Weight Reduction)
05/2022 - 01/2015
9Diabetic Retinopathy (Retinopathy, Diabetic)
10/2014 - 08/2009
8Esophageal Squamous Cell Carcinoma
01/2022 - 02/2008
8Neoplasm Metastasis (Metastasis)
01/2022 - 05/2011
8Cognitive Dysfunction
01/2022 - 05/2014
8Leukemia
01/2021 - 09/2008
8Cerebral Hemorrhage
01/2020 - 09/2015
7Stroke (Strokes)
07/2022 - 11/2014
7Periodontitis
01/2022 - 01/2017
7Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 11/2014
7Breast Neoplasms (Breast Cancer)
01/2022 - 11/2016
6Fibrosis (Cirrhosis)
08/2022 - 01/2017
6Colorectal Neoplasms (Colorectal Cancer)
05/2022 - 01/2018
6Alveolar Bone Loss
01/2022 - 01/2017
6Ocular Hypertension (Glaucoma, Suspect)
01/2022 - 01/2019
6Glaucoma
01/2022 - 01/2016
6Schizophrenia (Dementia Praecox)
01/2022 - 01/2019
6Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 04/2015
6Bone Resorption
01/2022 - 01/2017
6Obesity
06/2021 - 01/2019
6Leukostasis
07/2014 - 08/2009
5Optic Nerve Injuries
01/2022 - 11/2008
5Hepatocellular Carcinoma (Hepatoma)
01/2022 - 08/2006
5Glioma (Gliomas)
01/2022 - 02/2017
5COVID-19
09/2021 - 01/2020
5Esophageal Neoplasms (Esophageal Cancer)
06/2021 - 07/2010
5Heart Failure
03/2021 - 01/2016
5Vascular Diseases (Vascular Disease)
01/2021 - 10/2009
5Hemorrhage
01/2021 - 01/2019
5Myocardial Infarction
01/2021 - 05/2015
5Neurodegenerative Diseases (Neurodegenerative Disease)
12/2020 - 01/2015
5Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2020 - 01/2016
5Body Weight (Weight, Body)
01/2018 - 01/2015
5Choroidal Neovascularization
01/2013 - 11/2007
4Glioblastoma (Glioblastoma Multiforme)
01/2022 - 11/2018
4Tuberculosis (Tuberculoses)
12/2021 - 02/2013
4Acute Lung Injury
11/2021 - 01/2013
4Anastomotic Leak
01/2021 - 04/2008
4Stomach Neoplasms (Stomach Cancer)
04/2020 - 01/2015
4Brain Ischemia (Cerebral Ischemia)
01/2020 - 01/2016
4Virus Diseases (Viral Diseases)
09/2019 - 03/2016

Drug/Important Bio-Agent (IBA)

36Proteins (Proteins, Gene)FDA Link
01/2022 - 02/2012
24Pharmaceutical PreparationsIBA
01/2022 - 01/2013
23Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2013
16Retinaldehyde (Retinal)IBA
01/2020 - 06/2009
14Oxygen (Dioxygen)IBA
01/2022 - 08/2009
12Messenger RNA (mRNA)IBA
08/2022 - 01/2018
11MicroRNAs (MicroRNA)IBA
05/2022 - 01/2014
11CytokinesIBA
01/2022 - 01/2014
11Biological ProductsIBA
01/2022 - 11/2008
11Therapeutic UsesIBA
03/2020 - 01/2013
10Peptides (Polypeptides)IBA
01/2022 - 10/2011
10erucylphosphocholineIBA
11/2021 - 01/2018
9Antiviral Agents (Antivirals)IBA
01/2022 - 01/2017
9Glucose (Dextrose)FDA LinkGeneric
01/2020 - 04/2011
8IronIBA
01/2021 - 06/2014
7Interleukin-6 (Interleukin 6)IBA
01/2022 - 05/2014
7Fenofibrate (CiL)FDA LinkGeneric
01/2022 - 01/2013
7Immune Checkpoint InhibitorsIBA
01/2022 - 11/2019
7EnzymesIBA
12/2021 - 04/2011
7RNA (Ribonucleic Acid)IBA
12/2021 - 12/2017
6Interleukin-10 (Interleukin 10)IBA
01/2022 - 05/2004
6Small Interfering RNA (siRNA)IBA
01/2022 - 01/2015
6DNA (Deoxyribonucleic Acid)IBA
01/2022 - 02/2012
6Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2022 - 01/2013
6Neuroprotective AgentsIBA
07/2021 - 01/2016
6LipidsIBA
06/2021 - 10/2014
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
07/2020 - 08/2009
5LipopolysaccharidesIBA
11/2021 - 08/2017
5AntioxidantsIBA
05/2021 - 01/2015
5Long Noncoding RNAIBA
04/2020 - 01/2016
5SynucleinsIBA
01/2020 - 11/2013
5Glycoproteins (Glycoprotein)IBA
11/2019 - 11/2018
5Polysaccharides (Glycans)IBA
10/2018 - 03/2016
4Insulin (Novolin)FDA Link
10/2022 - 11/2014
4Silicone OilsIBA
01/2022 - 01/2019
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 08/2009
4HydrogelsIBA
10/2021 - 10/2018
4Hormones (Hormone)IBA
01/2020 - 01/2015
4Indicators and Reagents (Reagents)IBA
01/2020 - 01/2014
4CelluloseIBA
06/2019 - 04/2011
4CollagenIBA
06/2019 - 11/2017

Therapy/Procedure

45Therapeutics
08/2022 - 06/2006
11Drug Therapy (Chemotherapy)
03/2022 - 04/2016
11Esophagectomy
01/2022 - 02/2008
8Ligation
01/2022 - 01/2017
7Bariatric Surgery
01/2021 - 12/2018
6Gastrectomy
05/2022 - 01/2019
5Immunotherapy
01/2022 - 01/2021
5Aftercare (After-Treatment)
01/2021 - 10/2012
5Lasers (Laser)
11/2019 - 02/2011
4Length of Stay
05/2021 - 10/2014